Cardioprotective Potential of Bitter Melon (Momordica charantia) Essential Oil: A Zebra Fish Model Study on Donepezil-HCl Induced Cardiotoxicity with Biochemical Analysis
Abstract
Background: Drug-induced cardiotoxicity is a major limitation in long-term pharmacotherapy and is often mediated through oxidative stress and inflammatory pathways. Donepezil, a widely prescribed acetylcholinesterase inhibitor, has been reported to induce adverse cardiovascular effects. Methods: The present study evaluated the cardioprotective potential of hexane-extracted Momordica charantia essential oil (MCEO) against Donepezil-induced cardiotoxicity using a zebrafish (Danio rerio) model. Antioxidant activity was assessed using DPPH radical scavenging and total antioxidant capacity assays, while anti-inflammatory activity was evaluated by red blood cell membrane stabilization. Gene expression of myeloperoxidase (MPO) and heat shock protein 70 (HSP70) was analyzed using RT-PCR in zebrafish heart tissue. Results: MCEO demonstrated significant free radical scavenging activity and concentration-dependent enhancement of total antioxidant capacity. The essential oil also exhibited marked anti-inflammatory activity by stabilizing erythrocyte membranes. Donepezil exposure significantly increased MPO expression and reduced HSP70 expression, indicating enhanced oxidative stress and inflammation. Treatment with MCEO significantly reduced MPO expression and restored HSP70 levels toward normal. Conclusion: The findings demonstrate that Momordica charantia essential oil exerts cardioprotective effects against Donepezil-induced cardiotoxicity through antioxidant and anti-inflammatory mechanisms. MCEO shows promise as a natural cardioprotective agent against drug-induced cardiac injury.
Downloads
References
Angom, R. S., & Nakka, N. M. R. (2024). Zebrafish as a model for cardiovascular and metabolic disease: The future of precision medicine. Biomedicines, 12(3), 693. https://doi.org/10.3390/biomedicines12030693
Azwanida, N. N. (2015). A review on the extraction methods used in medicinal plants: Principles, strength and limitation. Medicinal & Aromatic Plants, 4(3), 196http://dx.doi.org/10.4172/2167-0412.1000196
Bortolotti, M., Mercatelli, D., & Polito, L. (2019). Momordica charantia: A nutraceutical approach for inflammatory-related diseases. Frontiers in Pharmacology, 10, 486. https://doi.org/10.3389/fphar.2019.00486
Coppola, A., Lombari, P., Mazzella, E., Capolongo, G., Simeoni, M., Perna, A. F., Ingrosso, D., & Borriello, M. (2023). Zebrafish as a model of cardiac pathology and toxicity: Spotlight on uremic toxins. International Journal of Molecular Sciences, 24(6), 5656. https://doi.org/10.3390/ijms24065656
Dhillon-Richardson, R. M., Haugan, A. K., Lyons, L. W., McKenna, J. K., Bronner, M. E., &Martik, M. L. (2025). Reactivation of an embryonic cardiac neural crest transcriptional profile during zebrafish heart regeneration. Proceedings of the National Academy of Sciences, 122(25), e2423697122. https://doi.org/10.1073/pnas.2423697122
Grover, J. K., & Yadav, S. P. (2004). Pharmacological actions and potential uses of Momordica charantia: A review. Journal of Ethnopharmacology, 93(1), 123–132. https://doi.org/10.1016/j.jep.2004.03.035
Huang, Y., & Alsabbagh, M. W. (2020). Comparative risk of cardiac arrhythmias associated with acetylcholinesterase inhibitors used in treatment of dementias: A narrative review. Pharmacology Research & Perspectives, 8(4), e00622. https://doi.org/10.1002/prp2.622
Islam, S., Jalaluddin, M., &Hettiarachchy, N. S. (2011). Bioactive compounds of bitter melon genotypes (Momordica charantia L.) in relation to their physiological functions. Functional Foods in Health and Disease, 1(2), 61–74. https://doi.org/10.31989/ffhd.v1i2.139
Kamalambigeswari, R., Kamalesh, A., Shibin, B., et al. (2024). GC–MS and antioxidant activity analysis using organic solvent extracts of Leucas aspera. African Journal of Biological Sciences, 6(6), 880–890. https://www.afjbs.com/uploads/paper/2eb0f7360fc036744b6854ffc5afbfa4.pdf
Kamalambigeswari, R., Yadav, S. A., Sivaswamy, N., & Ushani, U. (2018). Isolation, identification, screening and optimization of pectinase producing soil fungi (Aspergillus niger). International Journal of Research in Pharmaceutical Sciences, 9(3), 762–768. https://doi.org/10.26452/ijrps.v9i3.1561
Kao, P. F., Cheng, C. H., Cheng, T. H., Liu, J. C., & Sung, L. C. (2024). Therapeutic potential of Momordicine I from Momordica charantia: Cardiovascular benefits and mechanisms. International Journal of Molecular Sciences, 25(19), 10518. https://doi.org/10.3390/ijms251910518
Khuanjing, T., Palee, S., Kerdphoo, S., Jaiwongkam, T., Anomasiri, A., Chattipakorn, S. C., &Chattipakorn, N. (2021). Donepezil attenuates doxorubicin-induced cardiotoxicity through reducing RIP1-mediated necroptosis. Pharmacological Research, 173, 105882. https://doi.org/10.1016/j.phrs.2021.105882
Lobo, V., Patil, A., Phatak, A., & Chandra, N. (2010). Free radicals, antioxidants and functional foods: Impact on human health. Pharmacognosy Reviews, 4(8), 118–126. https://doi.org/10.4103/0973-7847.70902
MacRae, C. A., & Peterson, R. T. (2015). Zebrafish as tools for drug discovery. Nature Reviews Drug Discovery, 14(10), 721–731. https://doi.org/10.1038/nrd4627
Malone, K., & Hancox, J. C. (2020). QT interval prolongation and Torsades de Pointes with donepezil, rivastigmine and galantamine. Therapeutic Advances in Drug Safety, 11, 2042098620942416. https://doi.org/10.1177/2042098620942416
Mladěnka, P., Applová, L., Patočka, J., Costa, V. M., Remião, F., Pourová, J., et al. (2018). Comprehensive review of cardiovascular toxicity of drugs and related agents. Medicinal Research Reviews, 38(4), 1332–1403. https://doi.org/10.1002/med.21476
OECD. (2013). Test No. 236: Fish embryo acute toxicity (FET) test. OECD Publishing. https://doi.org/10.1787/9789264203709-en
Shaikh, J. R., & Patil, M. K. (2020). Qualitative tests for preliminary phytochemical screening: An overview. International Journal of Chemical Studies, 8(2), 603–608. https://doi.org/10.22271/chemi.2020.v8.i2i.8834
Sharma, O. P., & Bhat, T. K. (2009). DPPH antioxidant assay revisited. Food Chemistry, 113(4), 1202–1205. https://doi.org/10.1016/j.foodchem.2008.08.008
Tan, S. P., Kha, T. C., Parks, S. E., & Roach, P. D. (2016). Bitter melon (Momordica charantia L.) bioactive composition and health benefits: A review. Food Reviews International, 32(2), 181–202. https://doi.org/10.1080/87559129.2015.1057843
Tanaka, A., Koga, S., & Hiramatsu, Y. (2009). Donepezil-induced adverse side effects of cardiac rhythm: Two case reports of atrioventricular block and torsade de pointes. Internal Medicine, 48(14), 1219–1223. https://doi.org/10.2169/internalmedicine.48.2181
World Health Organization. (2021). Cardiovascular diseases (CVDs): Key facts. https://www.who.int/en/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds)
Wu, Y., Zhang, H., Sun, F., Zhang, W., & Jiang, Z. (2026). An ex vivo zebrafish heart model for oxidative stress studies. Journal of Pharmacological and Toxicological Methods, 108408. https://doi.org/10.1016/j.vascn.2026.108408
Yoshime, L. T., de Melo, I. L. P., Sattler, J. A. G., de Carvalho, E. B. T., & Mancini-Filho, J. (2016). Bitter gourd (Momordica charantia L.) seed oil as a naturally rich source of bioactive compounds for nutraceutical purposes. Nutrire, 41(1), 12. https://doi.org/10.1186/s41110-016-0013-y

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
















.